Nashville Brain Institute (NBI) functions as a leading Neuropsychiatric facility committed to clinical and research efforts, with a focus on precise psychiatric diagnostics and interventions. This precise method examines the essential neurobiological elements contributing to mental health symptoms. Our objective is to design individualized, evidence-based reviews and approaches that address these root causes, helping to uncover neglected facets of mental conditions and deliver sustainable solutions for mental health issues. At NBI, our mental health professionals partner with neurologists to integrate neurobiology and psychiatry, allowing us to handle intricate neuropsychiatric disorders through detailed diagnostic techniques and treatment approaches, including neurotransmitter analyses, neuropsychological evaluations, Ketamine therapy, Ketamine-assisted therapy, TMS therapy, Suboxone therapy, and IOP group therapy.
Emerging Advances in Targeted Psychiatry
Nashville Brain Institute (NBI) serves as a specialized Neuropsychiatric center for clinical and research activities, concentrating on accurate psychiatric diagnosis and care. Targeted psychiatry involves exploring the fundamental neurobiological processes behind mental health symptoms. We strive to formulate personalized, measurement-guided assessments and therapies that target these core mechanisms, thus addressing overlooked aspects of mental disorders and providing lasting remedies for mental illness. At NBI, our mental health team works in tandem with neurologists to link neurobiology and psychiatry, empowering us to resolve complex neuropsychiatric conditions through extensive diagnostic strategies and therapeutic methods, such as neurotransmitter evaluations, cognitive tests, Ketamine treatment, Ketamine-enhanced psychotherapy, TMS treatment, Suboxone treatment, and IOP group therapy.